cerrar
Tagged with A

Hungary: Redefining Sustainability
With approximately $90 billion flowing into the country (according to the Hungarian Investment and Trade Agency) since it abolished its centrally…

Interview with Jean Paul Scheuer, General Manager, Sanofi Ukraine
What were the factors that led to Sanofi’s decision to establish an LLC in 2009 in Ukraine, and how has it changed your operations? Most of…

Interview with Denise QUEIROZ, General Manager, Erowlabs
You have 25 years of experience in the Brazilian pharmaceutical industry, witnessing the major transformations of this market and the fast emergence…

Interview with Viktor Shafranskyi, General Manager, IPSEN Ukraine
Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in…

Interview with John Fagan, General Manager, Sanofi SA
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an…

Interview with Krzysztof W. Siedlecki, General Manager, Astellas…
Since the establishment of Astellas’ predecessor Brocade in Russia in 1992, what has been Astellas’ evolution in Ukraine? Astellas has…

Interview with Paul Anley, Managing Director, Pharma Dynamics
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the…

Interview with Omar Ehsan, General Manager, IMS Health South…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your…

Interview with Linda Reid, Commercial Director, IMS Health South…
Mrs. Reid, how would you define and describe the generic part of the South African pharmaceutical market? Linda Reid: South Africa is very much a…

Interview with Nenad Pavletic, President, AstraZeneca Russia
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in…

Interview with André Bràzay, President, Sandoz Hungary
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already…

Interview with Zolt Szepeshàzi, General Manager Hungary &…
IMS is a strong brand name when it comes to pharma and healthcare information worldwide. Can you please elaborate on the particularities that set the…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here